Rising Threat of Infections Unfazed by Antibiotics

"...for a combination of business reasons and scientific challenges, the pharmaceuticals industry is pursuing very few drugs for Acinetobacter and other organisms of its type, known as Gram-negative bacteria. Meanwhile, the germs are evolving and becoming ever more immune to existing antibiotics."

Andrew Pollack
New York Times
February 26, 2010

Read article @ NYTimes.com